In short. Anatomical mapping is well described; a fall in complication rates has not been demonstrated by any comparative study.
Key points
- Can the technology show something?
- Yes, and that is established.
- Does showing it change how often something goes wrong?
The evidence for ultrasound in aesthetic injections is substantial in one direction and almost absent in the other. Separating the two is what makes it possible to say what a scan is for.
Anatomical mapping
This is the well-evidenced part. Imaging identifies the larger arteries of the face and their course, and the anatomical literature documents how much that course varies between individuals. The finding is consistent, it is reproducible in trained hands, and it is the reason the technique exists. It is also a statement about what can be seen rather than about what happens to anybody afterwards.
Detection of material in the wrong place
Injected material has been identified inside vessels on imaging, and the finding is reported in case reports and small series. It demonstrates that the technology can detect the consequence of a vascular event, which is genuinely useful for understanding what happened. It cannot establish a rate, because a case report describes one event, and it cannot establish that detecting material changes the outcome.
Two questions that are routinely merged
Can the technology show something? Yes, and that is established. Does showing it change how often something goes wrong? That is a different question, and it is the one that has not been answered. A finding and a benefit are not the same claim.
Why the prevention study does not exist
Establishing that scanning lowers complication rates requires a comparison: procedures performed with scanning against procedures performed without it, otherwise comparable, in numbers large enough to detect a difference in an uncommon event. Vascular occlusion is rare, which means the required sample is very large, and the study would have to be organised across many operators and centres to be meaningful. The cost and difficulty of that work are the honest explanation for its absence, and the absence is not evidence that scanning does not help.
What follows for a reader
That a scan is a reasonable way to obtain information about one person’s anatomy, and that it should not be described as a safeguard. The measures with clearer reasoning behind them — instrument choice, injection technique, site selection, and declining a treatment that is not needed — reduce risk without removing it, and imaging sits beside them rather than above them.
How to weigh an imaging claim
- Is the claim about what imaging shows, or about what it prevents?
- Is the evidence a case report, a series, or a comparison with a group that was not scanned?
- Does the claim rest on the equipment, or on the training of the person reading the image?
Grading by question rather than by technology keeps a solid anatomical finding from being spent on a prevention claim that no study has made.
Frequently asked questions
What is the strongest evidence for ultrasound in injections?
Anatomical description. Imaging reliably identifies the larger vessels of the face and their course, and studies document how that anatomy varies between individuals. That is a solid body of work and it is about what can be seen rather than about what is prevented.
Is there evidence that scanning prevents complications?
No comparative study has shown it. Establishing that would require procedures performed with and without scanning, comparable in every other respect, in numbers large enough to detect an uncommon event. Vascular occlusion is rare, so the required numbers are very large and the study has not been done.
Are case reports of material seen in vessels useful?
They are, as descriptions. They establish that imaging can identify injected material in the wrong place, which is a genuine capability. They cannot establish how often it happens, whether scanning changes it, or what the finding means for the person, because a case report describes one event rather than a rate.
Risks & Limitations
- A vascular occlusion is a rare but serious emergency; it can occur during an injection and no scan or technique removes the risk.
- Showing where a vessel runs does not prevent material entering it, because the risk arises while the needle is in the tissue.
- No comparative study has shown that routine scanning reduces how often vascular events happen.
- A normal-looking scan means a vessel was not identified at that plane and resolution, not that none is present.
- Imaging shows structure; it does not dissolve or reverse an occlusion, and it is not a treatment.
When to Seek Care
- Pain out of proportion to the procedure, or pain that is worsening rather than settling — seek emergency assessment immediately.
- Blanching, dusky discolouration or blistering of the skin in the treated area.
- Any change in vision, or severe pain behind the eye — this is an emergency, not an appointment.
- Contact the service that holds your records for anything else, rather than relying on a website.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — cleared diagnostic ultrasound devices and their indications
- European Medicines Agency (EMA) and national regulators — dermal filler safety communications
- National Medical Products Administration (NMPA, China) — approved injectable products and their indications
- National Institute for Health and Care Excellence (NICE, UK) — guidance on diagnostic imaging
- Cochrane Library — systematic reviews of ultrasound guidance for vascular access and injection
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.